Imported antimalarials are expensive and resistance is rising. Malaherb is Ghana's proven herbal alternative — derived from Cryptolepis sanguinolenta, clinically studied, and trusted for decades.
For years, the Bill & Melinda Gates Foundation subsidised Artemisinin-based Combination Therapies (ACTs), making imported drugs artificially cheap. When those subsidies were withdrawn, governments could not sustain the tab.
Today, imported antimalarials are expensive and increasingly out of reach for ordinary families. Meanwhile, drug resistance to synthetic treatments is a growing global concern.
The answer may not be a newer synthetic drug — it may already be growing in West Africa. Cryptolepis sanguinolenta has been used to treat malaria for generations. Malaherb is its clinically-formulated, standardised form.
A liquid herbal antimalarial derived from Cryptolepis sanguinolenta — a plant indigenous to West Africa and used in Ghana for generations to treat uncomplicated malaria.
Cryptolepis sanguinolenta is gaining international attention beyond malaria. Researchers in Ghana are investigating its potential against COVID-19. In the United States, it is used by practitioners treating Lyme disease, babesia, and bartonella.
This growing international interest reflects the depth of bioactivity in the plant — and validates what Ghanaian traditional medicine has known for centuries.
Malaherb is not folklore. It is a standardised extract backed by documented research.
The primary bioactive alkaloid in Cryptolepis sanguinolenta is cryptolepine, which has demonstrated antimalarial, antibacterial, anti-inflammatory, and antipyretic properties in research settings.
Clinical data on Malaherb was presented and published in the proceedings of the First International Seminar on Cryptolepis — an early dedicated research forum on the plant's therapeutic applications.
The WHO has formally recognised traditional medicine as a crucial component of healthcare in developing countries, and has run programmes to identify which traditional systems should be preserved for modern adaptation.
Source: Clinical efficacy data for Malaherb is documented in: Proceedings of the First International Seminar on Cryptolepis sanguinolenta. Crown Pharmacy has maintained formulation standards consistent with those trials since 1976.
Take before meals. Shake the bottle well before each use. Course: 3–5 days. For use by adults and children 12 years and above only.
Call or WhatsApp us directly. We'll arrange delivery or let you know the nearest stockist.
Mon – Fri, 8am – 5pm GMT. Orders can be arranged for delivery across Ghana.
Crown Pharmacy has been at the intersection of traditional knowledge and modern pharmacy standards since 1976. Malaherb is the product of that commitment — combining the time-tested power of Cryptolepis sanguinolenta with rigorous formulation discipline.